X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7347) 7347
Book Review (1890) 1890
Publication (530) 530
Magazine Article (43) 43
Conference Proceeding (41) 41
Book Chapter (36) 36
Newsletter (30) 30
Reference (10) 10
Book / eBook (9) 9
Newspaper Article (4) 4
Government Document (2) 2
Trade Publication Article (2) 2
Web Resource (2) 2
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6381) 6381
index medicus (6187) 6187
thalidomide - therapeutic use (3856) 3856
thalidomide (3414) 3414
male (3154) 3154
female (2939) 2939
middle aged (2378) 2378
thalidomide - analogs & derivatives (2296) 2296
oncology (2137) 2137
multiple myeloma - drug therapy (2097) 2097
aged (2086) 2086
hematology (1958) 1958
adult (1789) 1789
treatment outcome (1649) 1649
multiple myeloma (1623) 1623
thalidomide - administration & dosage (1593) 1593
antineoplastic combined chemotherapy protocols - therapeutic use (1543) 1543
thalidomide - adverse effects (1372) 1372
bortezomib (1279) 1279
lenalidomide (1196) 1196
antineoplastic agents - therapeutic use (1171) 1171
therapy (1070) 1070
animals (924) 924
aged, 80 and over (815) 815
angiogenesis inhibitors - therapeutic use (797) 797
chemotherapy (784) 784
care and treatment (778) 778
immunosuppressive agents - therapeutic use (759) 759
stem-cell transplantation (755) 755
dexamethasone (754) 754
cancer (749) 749
thalidomide - pharmacology (706) 706
dexamethasone - administration & dosage (691) 691
pharmacology & pharmacy (679) 679
abridged index medicus (634) 634
survival (597) 597
drug therapy (595) 595
recurrence (558) 558
prognosis (544) 544
multiple-myeloma (542) 542
multiple myeloma - therapy (534) 534
multiple myeloma - pathology (530) 530
antineoplastic combined chemotherapy protocols - adverse effects (500) 500
multiple myeloma - mortality (499) 499
medicine & public health (485) 485
transplantation (485) 485
angiogenesis (478) 478
aids/hiv (459) 459
research (455) 455
clinical trials as topic (446) 446
disease-free survival (445) 445
immunologic factors - therapeutic use (444) 444
retrospective studies (411) 411
mice (405) 405
trial (400) 400
hematology, oncology and palliative medicine (399) 399
remission induction (393) 393
analysis (382) 382
medicine, general & internal (377) 377
drug therapy, combination (376) 376
boronic acids - therapeutic use (375) 375
pyrazines - therapeutic use (375) 375
survival analysis (372) 372
health aspects (368) 368
dermatology (361) 361
follow-up studies (359) 359
dexamethasone - therapeutic use (357) 357
multiple myeloma - diagnosis (353) 353
boronic acids - administration & dosage (350) 350
pyrazines - administration & dosage (349) 349
disease progression (347) 347
dose-response relationship, drug (343) 343
risk factors (342) 342
antineoplastic agents - adverse effects (338) 338
immunology (338) 338
transplantation, autologous (338) 338
combined modality therapy (333) 333
necrosis-factor-alpha (329) 329
survival rate (323) 323
combination (321) 321
multiple myeloma - complications (312) 312
melphalan (309) 309
plus dexamethasone (308) 308
dosage and administration (305) 305
myelodysplastic syndromes - drug therapy (298) 298
clinical trials (296) 296
stem cell transplantation (294) 294
hematopoietic stem cell transplantation (288) 288
stem cells (279) 279
time factors (279) 279
efficacy (273) 273
drug administration schedule (272) 272
myeloma (272) 272
elderly-patients (271) 271
adolescent (268) 268
diagnosis (268) 268
cells (263) 263
article (261) 261
antineoplastic combined chemotherapy protocols - administration & dosage (256) 256
expression (255) 255
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
Gerstein Science - Stacks (4) 4
UTL at Downsview - May be requested (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Music - Stacks (1) 1
Online Resources - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6899) 6899
French (145) 145
Japanese (121) 121
German (78) 78
Chinese (69) 69
Spanish (57) 57
Czech (22) 22
Polish (19) 19
Portuguese (18) 18
Italian (13) 13
Dutch (10) 10
Danish (7) 7
Hebrew (6) 6
Swedish (4) 4
Hungarian (3) 3
Finnish (2) 2
Korean (2) 2
Russian (2) 2
Ukrainian (2) 2
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Crohn's and Colitis, ISSN 1873-9946, 10/2014, Volume 8, Issue 10, pp. 1179 - 1207
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 14, pp. 1591 - 1597
Journal Article
Cancer Cell, ISSN 1535-6108, 09/2012, Volume 22, Issue 3, pp. 345 - 358
Bortezomib therapy has proven successful for the treatment of relapsed/refractory, relapsed, and newly diagnosed multiple myeloma (MM); however, dose-limiting... 
DEUBIQUITINATING ENZYME | INACTIVATION | PROTEIN | THERAPY | ONCOLOGY | MDM2 | DEGRADATION | MECHANISMS | HAUSP | CANCER | P53 REGULATION | CELL BIOLOGY | Thiophenes - therapeutic use | Apoptosis - drug effects | Humans | Molecular Sequence Data | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Thalidomide - pharmacology | Boronic Acids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Protease Inhibitors - pharmacology | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Dexamethasone - pharmacology | Antineoplastic Agents - pharmacology | Drug Therapy, Combination | Multiple Myeloma - enzymology | Protease Inhibitors - therapeutic use | Proto-Oncogene Proteins c-mdm2 - metabolism | Ubiquitin Thiolesterase - antagonists & inhibitors | Bortezomib | Cyclin-Dependent Kinase Inhibitor p21 - antagonists & inhibitors | Thiophenes - pharmacology | Random Allocation | Mice, SCID | Ubiquitin Thiolesterase - genetics | Xenograft Model Antitumor Assays | Dexamethasone - therapeutic use | Multiple Myeloma - pathology | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Mice | Thalidomide - therapeutic use | Pyrazines - pharmacology | Ubiquitin-Specific Peptidase 7 | Boronic Acids - pharmacology | Drug Resistance, Neoplasm - drug effects | Medical colleges | Dexamethasone | Proteases | Analysis | Multiple myeloma | Lymphomas | Apoptosis | Index Medicus
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2015, Volume 90, Issue 11, pp. 981 - 985
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10068, pp. 519 - 527
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 8, pp. 1589 - 1596
The Spanish Myeloma Group conducted a trial to compare bortezomib/thalidomide/dexamethasone (VTD) versus thalidomide/dexamethasone (TD) versus vincristine,... 
TRIAL | SURVIVAL | PLUS DEXAMETHASONE | COMPLETE REMISSION | HIGH-DOSE THERAPY | COMPLETE RESPONSE | DOXORUBICIN | PERIPHERAL NEUROPATHY | CONTINUED STANDARD CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Boronic Acids - toxicity | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Dexamethasone - toxicity | Induction Chemotherapy | Male | Transplantation, Autologous | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Antineoplastic Agents - administration & dosage | Boronic Acids - therapeutic use | Antineoplastic Agents - toxicity | Multiple Myeloma - therapy | Pyrazines - toxicity | Antineoplastic Agents - adverse effects | Female | Boronic Acids - administration & dosage | Thalidomide - adverse effects | Bortezomib | Dexamethasone - administration & dosage | Multiple Myeloma - diagnosis | Thalidomide - administration & dosage | Thalidomide - toxicity | Antineoplastic Combined Chemotherapy Protocols - toxicity | Disease-Free Survival | Dexamethasone - therapeutic use | Multiple Myeloma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Stem Cells - drug effects | Stem Cells - pathology | Aged | Hematopoietic Stem Cell Transplantation - methods | Thalidomide - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article